NEU neuren pharmaceuticals limited

Ann: Neuren submits 3 NNZ-2591 Orphan Drug applications to FDA, page-7

  1. 1,553 Posts.
    lightbulb Created with Sketch. 2333
    Its incredible to contemplate that Neuren could go-it-alone in taking NNZ-2591 through to approval, funded by milestone payments from Trofinetide. I would assume that the opportunity to gain approval off a successful Phase 2 trial would be enhanced by Orphan Drug approval. Trofinetide will also light up the clinical pathway for its sibling.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.85
Change
0.000(0.00%)
Mkt cap ! $1.598B
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 16 $14.07
 

Sellers (Offers)

Price($) Vol. No.
$12.07 152 6
View Market Depth
Last trade - 09.59am 18/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.